FDA Approves low dose gondolinium for Enhanced MRI Imaging in Adults and Children

The Food and Drug Administration (FDA) has approved low dose gondolinium Ambelvist® (gadoquatrane) for use with magnetic resonance imaging (MRI) in adult and pediatric patients, including term...